ClearPoint Neuro, Inc. (CLPT)
$10.20-2.67%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $306M
- Beta
- 1.29
- P/E (TTM)
- -9.33
- Short % float
- 18.13%
- Days to cover
- 6.0
- SI change
- +10.0%
- 1W
- -11.46%
- 1M
- -25.66%
- vs SPY 1W
- -11.88%
- vs SPY 1M
- -27.72%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 12
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-112.9%
REV YoY-
ROE-188.1%
EPS YoY-
ROA-39.8%
GROSS63
OP-73
NET-82
[VALUATION]
P/E TTM-9.33
P/E FWD-
SECTOR PE20.54
INDUSTRY PE22.84
P/B30.51
P/FCF-
EV/EBITDA-13.30
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E593.41
ALTMAN Z-
CURR RATIO4.73
ND/EBITDA-
BETA1.29
Company news
FAQ
- What is LOPJLB’s current signal on CLPT?
- LOPJLB’s latest quantitative signal on ClearPoint Neuro, Inc. (CLPT) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CLPT in?
- ClearPoint Neuro, Inc. (CLPT) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ClearPoint Neuro, Inc. (CLPT) do?
- ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of dee…